{
    "organizations": [],
    "uuid": "7db718f1dfb34cfef93444d0504ee3170c240537",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-impax-shareholders-approve-propose/brief-impax-shareholders-approve-proposed-business-combination-with-amneal-idUSFWN1R90UN",
    "ord_in_thread": 0,
    "title": "BRIEF-Impax Shareholders Approve Proposed Business Combination With Amneal",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - Impax Laboratories Inc:\n* IMPAX SHAREHOLDERS APPROVE PROPOSED BUSINESS COMBINATION WITH AMNEAL\n* IMPAX LABORATORIES INC - AT MEETING, 51.8 MILLION SHARES, OR APPROXIMATELY 99% OF VOTES CAST, VOTED IN FAVOR OF BUSINESS COMBINATION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-28T04:18:00.000+03:00",
    "crawled": "2018-03-28T18:53:12.019+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "impax",
        "laboratory",
        "inc",
        "impax",
        "shareholder",
        "approve",
        "proposed",
        "business",
        "combination",
        "amneal",
        "impax",
        "laboratory",
        "inc",
        "meeting",
        "million",
        "share",
        "approximately",
        "vote",
        "cast",
        "voted",
        "favor",
        "business",
        "combination",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}